drugset / Trial / NCT01783964

Elacytarabine Mass Balance Study in Healthy Volunteers

NCT01783964

Phase 1 Completed 6 enrolled Clavis Pharma
NaSingle-groupOpen-labelBasic science

Summary

This study is performed to measure the quantity of i.v. applied elacytarabine that leave the body, by which route and how fast.

Timeline

Start
2013-02
Primary completion
2013-02
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Elacytarabine Small molecule Intravenous

Indications

No indication recorded.